Numis Securities Ltd reissued their buy rating on shares of Abzena PLC (LON:ABZA) in a research report sent to investors on Thursday. They currently have a GBX 80 ($1.03) target price on the stock.

Separately, FinnCap restated a buy rating and set a GBX 80 ($1.03) price target on shares of Abzena PLC in a research report on Wednesday, August 30th.

Shares of Abzena PLC (LON:ABZA) opened at 34.00 on Thursday. The company’s market cap is GBX 46.87 million. The firm’s 50-day moving average price is GBX 45.41 and its 200 day moving average price is GBX 41.25. Abzena PLC has a 52 week low of GBX 31.00 and a 52 week high of GBX 66.00.

ILLEGAL ACTIVITY WARNING: This piece of content was first reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this piece of content on another domain, it was illegally copied and reposted in violation of United States & international copyright legislation. The correct version of this piece of content can be read at

Abzena PLC Company Profile

Abzena plc is a life sciences company. The Company provides technologies and complementary services to enable the development and manufacture of biopharmaceutical products. It has a global customer base which includes approximately 20 biopharmaceutical companies, as well as large and small biotech companies and academic groups.

Receive News & Stock Ratings for Abzena PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abzena PLC and related stocks with our FREE daily email newsletter.